Immune Targeting Systems its-innovation.co.uk


Public list: Pharma Startups (4732) Portfolio Company Matchmaking M&A (394)

Immune Targeting System is a London based vaccine company developing vaccines for mutating viruses. The company's synthetic T cell platform aims to allow to develop vaccines for the prevention and treatment of major life-threatening viral infections of global impact, including pandemic and seasonal influenza.

Immune Targeting System is a London based vaccine company developing vaccines for mutating viruses. The company's synthetic T cell platform aims to allow to develop vaccines for the prevention and treatment of major life-threatening viral infections ...Show all

Company (Acquired)

Phone: +44 20 7691 4908

Fax:

London Bioscience Innovation, Centre
2 Royal College Street
London, NW1 0NH
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Immune Targeting Systems $28M Feb 20, 2015
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Immune Targeting Systems Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

Iomai Corporation

Gaithersburg, Maryland, United States
AcquiredIomai Corporation is developing vaccines and immune system stimulants delivered through needle-free transcutaneous immunizationLogin to see details

VaxInnate Corporation

Cranbury, New Jersey, United States
Dead / InactiveVaxInnate is a privately-held biotechnology company in Cranbury, NJ that is developing a technology platform for use in developing novel and proprietary vaccines. VaxInnate's vaccines focus on infectious diseases, including seasonal and pandemic flu, dengue, and Clostridium difficile. VaxInnate's technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of vaccines. VaxInnate has already generated positive Phase 1, and in some instances Phase...Show allLogin to see details
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Influenza antigen delivery vectors and constructs Dec 23, 2013 Sep 20, 2016 Patent
Antigen delivery vectors and constructs Jan 20, 2012 Jun 24, 2014 Patent
Influenza antigen delivery vectors and constructs Aug 29, 2008 Feb 04, 2014 Patent
Antigen delivery vectors and constructs Sep 10, 2008 Mar 06, 2012 Patent
Antigen delivery vectors and constructs Feb 04, 2010 Feb 07, 2012 Patent
See all 8 patents